Page 7 of 7
Journal of Medicinal Chemistry
of vitamin D(3) metabolism initiated by P450scc and modified by
CYP27B1. FASEB J. 2012, 26, 3901-3915.
product of vitamin D3 hydroxylation by P450scc, decreases NF-kappaB
activity by increasing IkappaB alpha levels in human keratinocytes. PLoS
One 2009, 4, e5988.
1
2
3
4
5
6
7
8
8.
Slominski, A. T.; Li, W.; Kim, T. K.; Semak, I.; Wang, J.; Zjawiony,
J. K.; Tuckey, R. C. Novel activities of CYP11A1 and their potential
physiological significance. J. Steroid Biochem. Mol. Biol. 2015, 151, 25-37.
20.
Slominski, A.; Janjetovic, Z.; Tuckey, R. C.; Nguyen, M. N.;
Bhattacharya, K. G.; Wang, J.; Li, W.; Jiao, Y.; Gu, W.; Brown, M.;
Postlethwaite, A. E. 20S-hydroxyvitamin D3, noncalcemic product of
CYP11A1 action on vitamin D3, exhibits potent antifibrogenic activity in
vivo. J. Clin. Endocrinol. Metab. 2013, 98, E298-303.
9.
Slominski, A. T.; Kim, T. K.; Li, W.; Yi, A. K.; Postlethwaite, A.;
Tuckey, R. C. The role of CYP11A1 in the production of vitamin D
metabolites and their role in the regulation of epidermal functions. J.
Steroid Biochem. Mol. Biol. 2014, 144 Pt A, 28-39.
21.
Wang, Q.; Lin, Z.; Kim, T. K.; Slominski, A. T.; Miller, D. D.; Li, W.
10.
Slominski, A. T.; Kim, T. K.; Li, W.; Postlethwaite, A.; Tieu, E. W.;
Total synthesis of biologically active 20S-hydroxyvitamin D3. Steroids 2015,
104, 153-162.
Tang, E. K.; Tuckey, R. C. Detection of novel CYP11A1-derived secosteroids
in the human epidermis and serum and pig adrenal gland. Sci. Rep. 2015,
5, 14875.
9
22.
Chen, J.; Wang, J.; Kim, T. K.; Tieu, E. W.; Tang, E. K.; Lin, Z.;
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Kovacic, D.; Miller, D. D.; Postlethwaite, A.; Tuckey, R. C.; Slominski, A. T.;
Li, W. Novel vitamin D analogs as potential therapeutics: metabolism,
toxicity profiling, and antiproliferative activity. Anticancer Res. 2014, 34,
2153-2163.
11.
Slominski, A. T.; Kim, T. K.; Janjetovic, Z.; Tuckey, R. C.; Bieniek,
R.; Yue, J.; Li, W.; Chen, J.; Nguyen, M. N.; Tang, E. K.; Miller, D.; Chen, T. C.;
Holick, M. 20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D
with potent antiproliferative and prodifferentiation activities in normal
and malignant cells. Am. J. Physiol. Cell Physiol. 2011, 300, C526-541.
23.
Xiao, M.; Wang, J.; Lin, Z.; Lu, Y.; Li, Z.; White, S. W.; Miller, D.
D.; Li, W. Design, synthesis and structure-activity relationship studies of
novel survivin inhibitors with potent anti-proliferative properties. PLoS
One 2015, 10, e0129807.
12.
Kim, T. K.; Wang, J.; Janjetovic, Z.; Chen, J.; Tuckey, R. C.;
Nguyen, M. N.; Tang, E. K.; Miller, D.; Li, W.; Slominski, A. T. Correlation
between secosteroid-induced vitamin D receptor activity in melanoma
cells and computer-modeled receptor binding strength. Mol. Cell.
Endocrinol. 2012, 361, 143-152.
24.
Lin, Z.; Marepally, S. R.; Ma, D.; Myers, L. K.; Postlethwaite, A.
E.; Tuckey, R. C.; Cheng, C. Y.; Kim, T. K.; Yue, J.; Slominski, A. T.; Miller, D.
D.; Li, W. Chemical synthesis and biological activities of 20S,24S/R-
dihydroxyvitamin D3 epimers and their 1alpha-hydroxyl derivatives. J.
Med. Chem. 2015, 58, 7881-7887.
13.
Slominski, A. T.; Kim, T. K.; Takeda, Y.; Janjetovic, Z.; Brozyna, A.
A.; Skobowiat, C.; Wang, J.; Postlethwaite, A.; Li, W.; Tuckey, R. C.; Jetten,
A. M. RORalpha and ROR gamma are expressed in human skin and serve
as receptors for endogenously produced noncalcemic 20-hydroxy- and
20,23-dihydroxyvitamin D. FASEB J. 2014, 28, 2775-2789.
25.
Li, W.; Chen, J.; Janjetovic, Z.; Kim, T. K.; Sweatman, T.; Lu, Y.;
Zjawiony, J.; Tuckey, R. C.; Miller, D.; Slominski, A. Chemical synthesis of
20S-hydroxyvitamin D3, which shows antiproliferative activity. Steroids
2010, 75, 926-935.
14.
Tuckey, R. C.; Li, W.; Shehabi, H. Z.; Janjetovic, Z.; Nguyen, M.
N.; Kim, T. K.; Chen, J.; Howell, D. E.; Benson, H. A. E.; Sweatman, T.;
Baldisseri, D. M.; Slominski, A. Production of 22-hydroxy metabolites of
vitamin D-3 by cytochrome P450scc (CYP11A1) and analysis of their
biological activities on skin cells. Drug Metab. Dispos. 2011, 39, 1577-
1588.
26.
Lu, Y.; Chen, J.; Janjetovic, Z.; Michaels, P.; Tang, E. K.; Wang, J.;
Tuckey, R. C.; Slominski, A. T.; Li, W.; Miller, D. D. Design, synthesis, and
biological action of 20R-hydroxyvitamin D3. J. Med. Chem. 2012, 55,
3573-3577.
27.
Tang, E. K.; Li, W.; Janjetovic, Z.; Nguyen, M. N.; Wang, Z.;
15.
Slominski, A. T.; Janjetovic, Z.; Fuller, B. E.; Zmijewski, M. A.;
Slominski, A.; Tuckey, R. C. Purified mouse CYP27B1 can hydroxylate
20,23-dihydroxyvitamin D3, producing 1alpha,20,23-trihydroxyvitamin D3,
which has altered biological activity. Drug Metab. Dispos. 2010, 38, 1553-
1559.
Tuckey, R. C.; Nguyen, M. N.; Sweatman, T.; Li, W.; Zjawiony, J.; Miller, D.;
Chen, T. C.; Lozanski, G.; Holick, M. F. Products of vitamin D3 or 7-
dehydrocholesterol metabolism by cytochrome P450scc show anti-
leukemia effects, having low or absent calcemic activity. PLoS One 2010, 5,
e9907.
28.
Lin, Z.; Yang, R.; Guan, Z.; Chen, A.; Li, W. Ultra-performance LC
separation and quadrupole time-of-flight MS identification of major
alkaloids in Plumula Nelumbinis. Phytochem. Anal. 2014, 25, 485-494.
16.
Slominski, A. T.; Janjetovic, Z.; Kim, T. K.; Wright, A. C.; Grese, L.
N.; Riney, S. J.; Nguyen, M. N.; Tuckey, R. C. Novel vitamin
D
29.
Pingili, A. K.; Kara, M.; Khan, N. S.; Estes, A. M.; Lin, Z.; Li, W.;
hydroxyderivatives inhibit melanoma growth and show differential effects
on normal melanocytes. Anticancer Res. 2012, 32, 3733-3742.
Gonzalez, F. J.; Malik, K. U. 6beta-hydroxytestosterone, a cytochrome
P450 1B1 metabolite of testosterone, contributes to angiotensin II-
induced hypertension and its pathogenesis in male mice. Hypertension
2015, 65, 1279-1287.
17.
Janjetovic, Z.; Brozyna, A. A.; Tuckey, R. C.; Kim, T. K.; Nguyen,
M. N.; Jozwicki, W.; Pfeffer, S. R.; Pfeffer, L. M.; Slominski, A. T. High basal
NF-kappaB activity in nonpigmented melanoma cells is associated with an
enhanced sensitivity to vitamin D3 derivatives. Br. J. Cancer 2011, 105,
1874-1884.
30.
Cheng, C. Y.; Slominski, A. T.; Tuckey, R. C. Metabolism of 20-
hydroxyvitamin D3 by mouse liver microsomes. J. Steroid Biochem. Mol.
Biol. 2014, 144 Pt B, 286-293.
18.
Janjetovic, Z.; Tuckey, R. C.; Nguyen, M. N.; Thorpe, E. M., Jr.;
31.
Tang, E. K.; Chen, J.; Janjetovic, Z.; Tieu, E. W.; Slominski, A. T.;
Slominski, A. T. 20,23-dihydroxyvitamin D3, novel P450scc product,
stimulates differentiation and inhibits proliferation and NF-kappaB
activity in human keratinocytes. J. Cell. Physiol. 2010, 223, 36-48.
Li, W.; Tuckey, R. C. Hydroxylation of CYP11A1-derived products of vitamin
D3 metabolism by human and mouse CYP27B1. Drug Metab. Dispos.
2013, 41, 1112-1124.
19.
Janjetovic, Z.; Zmijewski, M. A.; Tuckey, R. C.; DeLeon, D. A.;
32.
Meyaard, L. The inhibitory collagen receptor LAIR-1 (CD305). J.
Nguyen, M. N.; Pfeffer, L. M.; Slominski, A. T. 20-Hydroxycholecalciferol,
Leukoc. Biol. 2008, 83, 799-803.
Table of Contents graphic
ACS Paragon Plus Environment